Consensus Scilex Holding Company

Equities

SCLX

US80880W1062

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
0.8805 ^USD	+2.29%		-1.93%	-56.84%

Apr. 16	Scilex Issues Preliminary Q1 Sales Results for ZTlido	MT
Mar. 20	Scilex Seeks FDA Approval to Add Dosing Guidance to Gout Treatment Drug Label	MT

Evolution of the average Target Price on Scilex Holding Company

Price target over the last 5 years

History of analyst recommendation changes

dd03d80691acd6.zcYWtPZJAyJVl_wPNeucCWjDuZp8RaIXqpDSAtoFgfk.uLI73J4lOxpt0oVYdqnMPRGN9dlKApZH6Karc-5S28urqi6GvT1lQ3iulw~80a126ad78a9e7ad0ba32ce6f962b9c9

Analyst Recommendations on Scilex Holding Company

B. Riley Starts Scilex Holding at Buy With $4 Price Target	23-10-16	MT
HC Wainwright Starts Scilex Holding at Buy With $12 Price Target	23-10-09	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

0.8805 USD

Average target price

6.833 USD

Spread / Average Target

+676.07%

High Price Target

12 USD

Spread / Highest target

+1,262.86%

Low Price Target

4 USD

Spread / Lowest Target

+354.29%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Scilex Holding Company

B. Riley
HC Wainwright

Ratings for Scilex Holding Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar